Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease

American Journal of Nephrology

Volumn 34, Issue 5, 2011, Pages 468-475

  Zhou, Li ^a   Liu, Fei ^a   Huang, Xiao R ^b   Liu, Fang ^a   Chen, Haiyong ^b   Chung, Arther C K ^b   Shi, Jianjian ^c   Wei, Lei ^c   Lan, Hui Y ^b   Fu, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cubilin; Diabetic kidney disease; Megalin; ROCK; Tubular cells, albuminuria

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALBUMIN; COLLAGEN TYPE 1; CUBILIN; GLUCOSE; INTERLEUKIN 1BETA; MEGALIN; RHO KINASE; RHO KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC KIDNEY DISEASE; DISEASE COURSE; IN VITRO STUDY; KIDNEY DISEASE; KIDNEY TUBULE ABSORPTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; STREPTOZOCIN DIABETES; URINARY EXCRETION; WILD TYPE;

ALBUMINURIA; AMIDES; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; PYRIDINES; RHO-ASSOCIATED KINASES;

EID: 80053493506     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000332040     Document Type: Article

References (42)

1. Soldatos G, Cooper ME: Diabetic nephropathy: important pathophysiologic mechanisms. Diabetes Res Clin Pract 2008; 82 (suppl 1):S75-S79.
2. Tojo A, Onozato ML, Ha H, Kurihara H, Sakai T, Goto A, Fujita T, Endou H: Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats. Histochem Cell Biol 2001; 116: 269-276. (Pubitemid 32930140)
3. Gekle M, Knaus P, Nielsen R, Mildenberger S, Freudinger R, Wohlfarth V, Sauvant C, Christensen EI: Transforming growth factor-P1 reduces megalin-and cubilin-mediat-ed endocytosis of albumin in proximal-tubule-derived opossum kidney cells. J Physiol 2003; 552:471-481. (Pubitemid 37321845)
4. Ishibashi F: High glucose increases phos-phocofilin via phosphorylation of LIM ki-nase due to Rho/Rho kinase activation in cultured pig proximal tubular epithelial cel ls. Diabetes Res Clin Pract 2007; 80: 24-33.
5. Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR: Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 2008; 57: 714-723.
6. Kikuchi Y, Yamada M, Imakiire T, Kushiya-ma T, Higashi K, Hyodo N, Yamamoto K, Oda T, Suzuki S, Miura S: A Rho-kinase inhibitor, fasudile, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. J Endocrinol 2007; 193: 595-603. (Pubitemid 46455962)
7. Ishizaki T, Naito M, Fujisawa K, Maeka-wa M, Watanabe N, Saito Y, Narumiya S: p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett 1997; 404:118-124. (Pubitemid 27113436)
8. Riento K, Ridley AJ: ROCKs: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003; 4:446-456. (Pubitemid 36648590)
9. Fukata M, Kaibuchi K: Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat Rev Mol Cell Biol 2001; 2:887-897. (Pubitemid 33674088)
10. Zhang YM, Bo J, Taffet GE, Chang J, Shi J, Reddy AK, Michael LH, Schneider MD, Ent-man ML, Schwartz RJ, Wei L: Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fi-brosis. FASEB J 20 06; 20: 916-9 2 5. (Pubitemid 44943949)
11. Fu P, Liu F, Wang W, Huang XR, Entman ML, Schwartz RJ, Wei L, Lan HY: Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol 2006; 17:3105-3114. (Pubitemid 44707770)
12. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC: A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross-reactivity and retrieve antigens. J Histochem Cy tochem 1995; 43: 97-102.
13. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14:1535-1548. (Pubitemid 36687055)
14. Zhou L, Fu P, Huang XR, Liu F, Lai KN, Lan HY: Activation of p53 Promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol 2010; 21:31-41.
15. Gojo A, Utsu nomiya K, Ta niguchi K, Yokota T, Ishiz awa S, Ka naz awa Y, Kurat a H, Tajima N: T he R ho-k i na se i n h ibitor, fa sud i l, at tenu-ates diabetic nephropathy in streptozotocin-induced diabetic rats. Eur J Pharmacol 2007; 568:242-247. (Pubitemid 46976901)
16. Zhai XY, Nielsen R, Birn H, Drumm K, Mildenberger S, Freudinger R, Moestrup SK, Verroust PJ, Christensen EI, Gekle M: Cubi-lin-and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney. Kidney Int 2000; 58: 1523-1533.
17. Christensen EI, Birn H, Verroust P, Moes-trup SK: Membrane receptors for endocyto-sis in the renal proximal tubule. Int Rev Cy-tol 1998; 180: 237-284. (Pubitemid 28122166)
18. Sahali D, Mulliez N, Chatelet F, Dupuis R, Ronco P, Verroust P: Characterization of a 280-kDa protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Teratogenic effect of the specific monoclonal antibodies. J Exp Med 1988; 167: 213-218. (Pubitemid 18093704)
19. Lebeau C, Arlt VM, Schmeiser HH, Boom A, Verroust PJ, Devuyst O, Beauwens R: Aris-tolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int 2001; 60: 1332-1342. (Pubitemid 32960027)
20. Norden AG, Lapsley M, Igarashi T, Kelleher CL, Lee PJ, Matsuyama T, Scheinman SJ, Shi-raga H, Sundin DP, Thakker RV, Unwin RJ, Verroust P, Moestrup SK: Urinary megalin deficiency implicates abnormal tubular en-docytic function in Fanconi syndrome. J Am Soc Nephrol 2002; 13: 125-133. (Pubitemid 34042019)
21. Obermüller N, Kränzlin B, Blum WF, Gretz N, Witzgall R: An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease. Am J Physiol Renal Physiol 2001; 280:F244-F253.
22. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339:1448-1456. (Pubitemid 28516069)
23. Eddy AA: Proteinuria and interstitial injury. Nephrol Dial Transplant 2004; 19: 277-281. (Pubitemid 38195969)
24. Reich HN, Tritchler D, Cattran DC, Herzen-berg AM, Eichinger F, Boucherot A, Henger A, Berthier CC, Nair V, Cohen CD, Scholey JW, Kretzler M: A molecular signature of proteinuria in glomerulonephritis. PLoS One 2010; 5:e13451.
25. Wolf G, Schroeder R, Ziyadeh FN, Stahl RA: Albumin up-regulates the type II transforming growth factor-p receptor in cultured proximal tubular cells. Kidney Int 2004; 66: 1849-1858. (Pubitemid 41094308)
26. Komers R, Oyama TT, Beard DR, Tikellis C, Xu B, Lotspeich DF, Anderson S: Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int 2011; 79: 432-442.
27. Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R, Krepinsky JC: RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 2008; 579: 1683-1692.
28. Tang S, Leung JC, Abe K, Chan KW, Chan LY, Chan TM, Lai KN: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003; 111: 515-527. (Pubitemid 36228009)
29. Shi J, Zhang L, Wei L: Rho-kinase in development and heart failure: insights from genetic models. Pediatr Cardiol 2011; 32:297-304.
30. Satoh K, Fukumoto Y, Shimokawa H: Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 2011; 301:H287-H296.
31. Fukushima M, Nakamuta M, Kohjima M, Kotoh K, Enjoji M, Kobayashi N, Nawata H: Fa-sudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int 2005; 25: 829-838. (Pubitemid 41038664)
32. Tada S, Iwamoto H, Nakamuta M, Sugimoto R, Enjoji M, Nakashima Y, Nawata H: A selective ROCK inhibitor, Y-27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol 2001; 34: 529-536. (Pubitemid 32328509)
33. Patel S, Takagi KI, Suzuki J, Imaizumi A, Kimura T, Mason RM, Kamimura T, Zhang Z: RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferen tiation. J Am Soc Nephrol 2005; 16: 1977-1984. (Pubitemid 41716428)
34. 1-induced a-smooth muscle actin expression during epithelial-mesen-chymal transition. Am J Physiol Renal Physiol 2003; 284:F911-F924. (Pubitemid 36443575)
35. Hutchison N, Hendry BM, Sharpe CC: Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells. Cell Signal 2009; 21: 1522-1531.
36. Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E, Hori M: Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002; 61: 1684-1695. (Pubitemid 34437922)
37. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T: Effect of fasudil on Rho-kinase and nephropathy in subtotally ne-phrectomized spontaneously hypertensive rats. Kidney Int 2003; 64:2009-2019. (Pubitemid 37449535)
38. Teraishi K, Kurata H, Nakajima A, Takaoka M, Matsumura Y: Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion- induced acute renal failure in rats. Eur J Pharmacol 2004; 505: 205-211. (Pubitemid 39535693)
39. Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y, Shimokawa H, Ono H, Matsuoka H: Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens 2004; 22:1787-1796. (Pubitemid 39141972)
40. Haudek SB, Gupta D, Dewald O, Schwartz RJ, Wei L, Trial J, Entman ML: Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardio-vasc Res 2009; 83:511-518.
41. Shi J, Zhang YW, Summers LJ, Dorn GW 2nd, Wei L: Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. J Mol Cell Cardiol 2008; 44: 551-560.
42. Lee DH, Shi J, Jeoung NH, Kim MS, Zabo-lotny JM, Lee SW, White MF, Wei L, Kim YB: Targeted disruption of ROCK1 causes insulin resistance in vivo. J Biol Chem 2009; 284: 11776-11780.